FindTrial
Sign In

Study for metagenomics of patients with novel coronavirus pneumonia (COVID-19)

Study for metagenomics of patients with novel coronavirus pneumonia (COVID-19)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000031104
Enrollment
Unknown
Registered
2020-03-22
Start date
2020-02-05
Completion date
Unknown
Last updated
2020-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Diagnosed Group:Nil
Suspending Group:Nil

Sponsors

The Fifth Affiliated Hospital of Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 90 Years

Inclusion criteria

Inclusion criteria: (1) Fever patients; (2) peoples who need to screen the novel coronavirus; (3) patients for possible infection with novel coronavirus through High throughput sequencing of pathogens; (4) Age and gender are not limited; (5) Patients has been diagnosed with 2019-nCoV pneumonia according to the latest version of 2019-nCoV pneumonia management guideline made by the national health commission of the People's Repulic of China.

Exclusion criteria

Exclusion criteria: (1) limited sample size; (2) Lack of sample information; (3) unable or failure to detect due to human error; (4) Abnormal results or failure in detection due to instrument or non-reagent quality problems.

Design outcomes

Primary

MeasureTime frame
Metagenomics Sequencing;—

Secondary

MeasureTime frame
Levels of inflammatory cytokines in peripheral blood;—

Countries

China

Contacts

Public ContactPengfei Pang

The Fifth Affiliated Hospital of Sun Yat-Sen University

pangpf@mail.sysu.edu.cn+86 18902536585

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026